You have 9 free searches left this month | for more free features.

Stage III solid tumor cancer

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Breast Cancer Undergoing Neoadjuvant Therapy

Recruiting
  • Stage I-III Breast Cancer
    • Hangzhou, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Dec 13, 2022

    Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 25, 2023

    Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,

    Recruiting
    • Advanced Bile Duct Carcinoma
    • +33 more
    • Sacramento, California
    • +6 more
    Aug 11, 2022

    Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

    Recruiting
    • Cancer
    • +11 more
    • San Antonio, Texas
      South Texas Accelerated Research Therapeutics, LLC
    Jun 21, 2023

    Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +7 more
    • Atlanta, Georgia
    • +2 more
    Nov 3, 2022

    Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester

    Recruiting
    • Advanced Pancreatic Carcinoma
    • +9 more
    • Endoscopic Ultrasound
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 13, 2022

    HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

    Active, not recruiting
    • HER2-positive Breast Cancer
    • +8 more
    • pNGVL3-hICD vaccine
    • +6 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Nov 1, 2022

    Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

    Not yet recruiting
    • Advanced Fallopian Tube Carcinoma
    • +10 more
    • Wee1 Inhibitor ZN-c3
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 25, 2023

    Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

    Completed
    • Male Breast Cancer
    • +7 more
    • propranolol hydrochloride
    • Correlative Studies
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 4, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +32 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +124 more
    Aug 24, 2022

    Active, not recruiting
    • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
    • +8 more
    • Cetuximab
    • +3 more
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Cancer Institute (UPCI)
    Jan 26, 2023

    Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • carboplatin chemotherapy
    • +2 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Nov 3, 2023

    Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

    Not yet recruiting
    • Limited Stage Lung Small Cell Carcinoma
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Nov 10, 2023

    Metastatic Malignant Solid Tumor, Recurrent Lung Small Cell Carcinoma, Recurrent Malignant Solid Tumor Trial in United States

    Terminated
    • Metastatic Malignant Solid Neoplasm
    • +8 more
    • Los Angeles, California
    • +13 more
    Oct 7, 2022

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Enrolling by invitation
    • Anatomic Stage I Breast Cancer AJCC v8
    • +29 more
    • Aromatherapy with Essential Oils and Virtual Reality
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 21, 2022

    Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +8 more
    • Imatinib Mesylate
    • Ipilimumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 1, 2022

    Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

    Not yet recruiting
    • Stage III NSCLC
    • Surgery
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Feb 21, 2023

    Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +3 more
    • Pulmonary Artery-First Surgical Technique
    • Biospecimen Collection
    • (no location specified)
    Aug 15, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Not yet recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +31 more
    • Diagnostic Laboratory Biomarker Analysis
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

    Available
    • Glioblastoma
    • +13 more
    • (no location specified)
    Jul 26, 2023

    Hepatocellular Carcinoma, Colorectal Cancer Trial in Hong Kong (Patient-Derived Tumor Organoids)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Colorectal Cancer
    • Patient-Derived Tumor Organoids
    • Hong Kong, N.t., Hong Kong
      Endoscopy Centre, Prince of Wales Hospital
    Oct 12, 2023

    Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

    Suspended
    • Brenner Tumor
    • +27 more
    • metformin hydrochloride
    • +2 more
    • Birmingham, Alabama
    • +9 more
    May 16, 2022

    Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

    Recruiting
    • Fallopian Tube Endometrioid Adenocarcinoma
    • +17 more
    • Biopsy
    • +3 more
    • Augusta, Georgia
    • +4 more
    Jan 25, 2023

    Defining Clinical Potential of Mass Response asBiomarker for

    Recruiting
    • Stage III Breast Cancer
    • +5 more
      • Columbus, Georgia
        Columbus Regional Research Institute, John B. Amos Cancer Center
      Jul 13, 2022